← back to search

Xiaofeng Wu

Chinese Academy of Medical Sciences & Peking Union Medical College · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cholangiocarcinoma and Gallbladder Cancer Studies, Pulmonary Hypertension Research and Treatments, Cancer-related molecular mechanisms research, and RNA modifications and cancer.
h-index
29
citations
3,528
works
163
NIH funding
primary concept
email

Recent publications

Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma
Cell Death and Disease 2024cited by 9position: lastdoi
Effect of different <scp>PD</scp>‐1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma
Alimentary Pharmacology & Therapeutics 2023cited by 10position: middledoi
Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China
The Clinical Respiratory Journal 2023cited by 9position: middledoi
Altered gut microbiota profile in patients with perimenopausal panic disorder
Frontiers in Psychiatry 2023cited by 6position: middledoi
Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study
Frontiers in Oncology 2022cited by 47position: middledoi
Luteolin Enhances Choroid Plexus 5-MTHF Brain Transport to Promote Hippocampal Neurogenesis in LOD Rats
Frontiers in Pharmacology 2022cited by 18position: middledoi
Copper transporter gene ATP7A: A predictive biomarker for immunotherapy and targeted therapy in hepatocellular carcinoma
International Immunopharmacology 2022cited by 14position: lastdoi
Decline of stress resilience in aging rats: Focus on choroid plexus-cerebrospinal fluid-hippocampus
The World Journal of Biological Psychiatry 2022cited by 10position: middledoi
A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma
Frontiers in Immunology 2022cited by 8position: middledoi
Learning curve and analysis of curative effects after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Chinese Medical Journal 2022cited by 1position: middledoi
Sintilimab plus anlotinib as first-line therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC).
Journal of Clinical Oncology 2021cited by 8position: middledoi
Predicting related factors of immunological response to hepatitis B vaccine in hemodialysis patients based on integration of decision tree classification and logistic regression
Human Vaccines & Immunotherapeutics 2021cited by 6position: middledoi
Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial
Journal for ImmunoTherapy of Cancer 2020cited by 159position: middledoi
Biomarkers of postmenopausal osteoporosis and interventive mechanism of catgut embedding in acupoints
Medicine 2020cited by 9position: middledoi
[Intragastric balloon for weight reduction: rationale, benefits, risks and indications].
PubMed 2020cited by 0position: lastdoi
Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
Journal of Immunotherapy 2019cited by 73position: middledoi
SHR-1210 plus GEMOX as first line treatment in biliary tract cancer: Results from a single-arm exploratory study.
Journal of Clinical Oncology 2019cited by 9position: middledoi
Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer
Cell 2018cited by 147position: middledoi
Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor
Nature Cell Biology 2017cited by 49position: firstdoi
Type D personality, illness perception, social support and quality of life in continuous ambulatory peritoneal dialysis patients
Psychology Health & Medicine 2016cited by 17position: middledoi
Prevalence and Risk Factors of Fluid Overload in Southern Chinese Continuous Ambulatory Peritoneal Dialysis Patients
PLoS ONE 2013cited by 79position: middledoi
Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma
Molecular Carcinogenesis 2012cited by 29position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaofeng Chen · Ningbo University5 papers (2019–2022)Fengjiao Zhao · Xuzhou Medical College4 papers (2019–2022)Yanhong Gu · China Pharmaceutical University4 papers (2019–2022)Yongqian Shu · Suzhou Municipal Hospital4 papers (2019–2022)Xiaofeng Qian · Nanjing Medical University3 papers (2019–2021)Xiangcheng Li · Guangxi University3 papers (2019–2022)Changxian Li · Qingdao Agricultural University3 papers (2020–2022)Xuehao Wang · Northwestern Polytechnical University3 papers (2012–2024)Yongxiang Xia · Academia Sinica3 papers (2020–2022)Qianwen Shao · Nanjing Medical University3 papers (2019–2021)Yunxiang Xu · Guangzhou University of Chinese Medicine2 papers (2020–2023)Wenjun Lu · Guangzhou University of Chinese Medicine2 papers (2022–2022)Dongqin Zhu · Wake Forest University2 papers (2019–2020)Yang Shao · Tianjin University of Traditional Chinese Medicine2 papers (2019–2020)Riken Chen · Xinjiang Medical University2 papers (2022–2023)Hanfang Xu · Guangzhou University of Chinese Medicine2 papers (2022–2022)Qunying Guo · Sun Yat-sen University2 papers (2013–2016)Haimin Liu · Shandong University of Technology2 papers (2022–2023)Feipeng Zhu · Nanjing Medical University2 papers (2019–2020)Gaohua Han · Nantong University2 papers (2019–2020)